301 related articles for article (PubMed ID: 12376959)
21. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.
Yotsuyanagi H; Shintani Y; Moriya K; Fujie H; Tsutsumi T; Kato T; Nishioka K; Takayama T; Makuuchi M; Iino S; Kimura S; Koike K
J Infect Dis; 2000 Jun; 181(6):1920-8. PubMed ID: 10837171
[TBL] [Abstract][Full Text] [Related]
22. [Abnormal expression of hepatitis B virus sequences integrated in human hepatocellular carcinomas].
Terris B; Marchio A; Mattei MG; Fagan E; Lok A; Tiollais P; Dejean A
Gastroenterol Clin Biol; 1992; 16(6-7):511-7. PubMed ID: 1326460
[TBL] [Abstract][Full Text] [Related]
23. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
24. Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinoma.
Yao DF; Wu XH; Su XQ; Yao M; Wu W; Qiu LW; Zou L; Meng XY
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):381-6. PubMed ID: 16911935
[TBL] [Abstract][Full Text] [Related]
25. Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.
Tamori A; Yamanishi Y; Kawashima S; Kanehisa M; Enomoto M; Tanaka H; Kubo S; Shiomi S; Nishiguchi S
Clin Cancer Res; 2005 Aug; 11(16):5821-6. PubMed ID: 16115921
[TBL] [Abstract][Full Text] [Related]
26. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
28. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
[TBL] [Abstract][Full Text] [Related]
29. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
30. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
[TBL] [Abstract][Full Text] [Related]
31. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
[TBL] [Abstract][Full Text] [Related]
32. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma.
Jicai Z; Zongtao Y; Jun L; Haiping L; Jianmin W; Lihua H
Mol Carcinog; 2006 Jul; 45(7):530-6. PubMed ID: 16649250
[TBL] [Abstract][Full Text] [Related]
33. State of hepatitis B viral genomes in cirrhotic and hepatocellular carcinoma nodules.
Aoki N; Robinson WS
Mol Biol Med; 1989 Oct; 6(5):395-408. PubMed ID: 2560524
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis.
Minami M; Daimon Y; Mori K; Takashima H; Nakajima T; Itoh Y; Okanoue T
Oncogene; 2005 Jun; 24(27):4340-8. PubMed ID: 15806150
[TBL] [Abstract][Full Text] [Related]
35. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
[TBL] [Abstract][Full Text] [Related]
36. Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators.
Schlüter V; Meyer M; Hofschneider PH; Koshy R; Caselmann WH
Oncogene; 1994 Nov; 9(11):3335-44. PubMed ID: 7936659
[TBL] [Abstract][Full Text] [Related]
37. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
38. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
